Aspartic acid unveils as antibiofilm agent and tobramycin adjuvant against mucoid and small colony variants of Pseudomonas aeruginosa isolates in vitro within cystic fibrosis airway mucus
Antibiotics are central to managing airway infections in cystic fibrosis (CF), yet current treatments often fail due to the presence of Pseudomonas aeruginosa biofilms, settling down the need for seeking therapies targeting biofilms. This study aimed to investigate the antibiofilm activity of aspart...
Saved in:
Main Authors: | Rosana Monteiro, Ana Margarida Sousa, Maria Olívia Pereira |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-06-01
|
Series: | Biofilm |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590207524000777 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Aqueous extracts of Moringa oleifera and Cinnamomum cassia as promising sources of antibiofilm compounds against mucoid and small colony variants of Pseudomonas aeruginosa and Staphylococcus aureus
by: Eduarda Silva, et al.
Published: (2025-06-01) -
Polymorphonuclear Leukocytes or Hydrogen Peroxide Enhance Biofilm Development of Mucoid Pseudomonas aeruginosa
by: Qi Tan, et al.
Published: (2018-01-01) -
Mutant Prevention Concentrations of Doripenem and Meropenem Alone and in Combination with Colistin (Polymyxin E), Levofloxacin and Tobramycin in Pseudomonas aeruginosa
by: George G Zhanel, et al.
Published: (2009-01-01) -
Pseudomonas Aeruginosa and Cystic Fibrosis: Antibiotic Therapy and the Science behind the Magic
by: Noni E MacDonald
Published: (1997-01-01) -
RNA-seq reproducibility of Pseudomonas aeruginosa in laboratory models of cystic fibrosis
by: Rebecca P. Duncan, et al.
Published: (2025-01-01)